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-/-CAMs 5. Discussion 6. Acknowledgements 7. References (TIMP-1) in CAMs. Confocal microscopy showed that collagen I deposition was mainly lied within lysosomes or autophagosomes in CD38 -/-or TGF-β treated CAMs. Collagen I deposition increased when CAMs lack CD38 expression or if autophagy was blocked, which is associated with impaired autophagic degradation of collagen I. This CD38 regulation of autophagic flux may represent a novel mechanism for extracellular matrix (ECM) plasticity of coronary arteries upon atherogenic stimulation.
INTRODUCTION
Vascular fibrosis, characterized by arterial wall thickening and excessive deposition of extracellular matrix (ECM), is one of the hallmarks of cardiovascular diseases such as atherosclerosis, restenosis, and heart failure (1). Collagens are the main component of ECM which contains several subtypes as I, III, IV, V and VI, with type I being most abundant in the vascular systems (2) . © 1996-2017 Excess formation or decreased degradation or both of collagen I may result in increased collagen I deposition, an event observed in the early stage of atherosclerosis (3) . Although many studies have been conducted to pursue the molecular mechanisms of collagen I degradation, the molecular mechanisms remain poorly understood.
Cluster of differentiation 38 (CD38) expresses broadly in immune cells, endothelial cells, vascular smooth muscle cells and endothelial progenitor cells which exerts multiple functions mainly by the production and metabolism of cyclic ADP-ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP) (4, 5) . The CD38/cADPR pathway contributes to the M1 receptor agonist-induced Ca 2+ release from the sarcoplasmic reticulum (SR) in coronary arterial myocytes (CAMs) (6) . NAADP has been reported to be the most potent intracellular Ca 2+ -mobilizing signaling. It has been proved that in arterial SMCs, NAADP mobilizes intracellular Ca 2+ through a two-pool mechanism by which NAADP releases Ca 2+ from a lysosome-dependent Ca 2+ store that in turn serves as a localized signal to trigger Ca 2+ -induced Ca 2+ release leading to global Ca 2+ increase in the cytosol (7) . It has been reported that Angiotensin II, endothelin-1, and norepinephrine cause vasoconstriction in renal, coronary or pulmonary arteries, depending on CD38 mediated Ca 2+ release (8) . CD38-mediated Ca 2+ mobilization in immunocyte has been reported to contribute to chemokine production, immunocyte infiltration, neutrophil adhesion and chemotaxis associated with cerebral injury after cardiac surgery (9, 10) and temporary ischemia and reperfusion of brain (11) . CD38-activated NAD(P)ase depletes endothelial NADPH profoundly inhibiting NO generation and endothelium-dependent relaxation of coronary artery, which contributes to contractile dysfunction and increases infarction of postischemic heart (12) . In addition, the CD38 immunopositive hepatic stellate cells (HSCs) were found to be attributed to liver fibrosis in patients with chronic hepatitis (13) . Recently, a growing body of evidence have shown that NAADP-sensitive lysosome-derived Ca 2+ and consequent increases in cytosolic Ca 2+ promoted autophagosome trafficking and fusion with lysosomes, a process named autophagic flux in CAMs, under both normal condition and atherogenic stimulation (14) , indicating that autophagic flux derangement may be a contributing factor to atherogenesis.
It has been known that autophagy is a critical cellular homeostatic process through which unnecessary or dysfunctional components of cells are degraded and/or recycled (15) . Autophagic process begins with the induction and formation of autophagosome that the cytoplasmic components are sequestrated in doublemembrane vesicles. Then, the autophagic flux consisting of autophagosomes trafficking and fusion with lysosomes to form autophagolysosomes and breakdown of autophagic contents in autophagolysosomes would happen (14) .
With respect to the pathogenic role of autophagic derangement, it has been reported that the kidneys from mice with deficient autophagic protein, beclin 1 exhibited profibrotic phenotype as shown by increased collagen deposition (16, 17) . The degradation of collagen by autophagy has also been suggested in alveolar epithelial cells and fibrotic lung tissues, hepeatic stellate cell as well as cardiac fibroblasts during fibrosis (18) . Rats treated with iloprost had a striking reduction of the right ventricular collagen deposition, which resulted from increased expression of autophagic genes accounting for collagen degradation (19) . TGF-β1 has been shown as an inducer of both collagen I synthesis and autophagy-mediated collagen I degradation, and in TGF-β1 treated cells inhibition of autophagy enhanced the collagen I deposition significantly (16) . In fibroblasts, a defective autophagy induced by alterations in the metabolic pathways or pharmacological handling could contribute to the excessive production of extracellular matrix by altering the turnover of collagen (20) . Moreover, enhanced autophagy was shown to exert a potent anti-aging influence on the arteries by increasing NO bioavailability, reducing oxidative stress and modifying structural factors (21) . Based on the central role of CD38 in regulating lysosomal transport and lysosomal fusion with autophagosome and the role of autophagy defects in fibrosis of various tissues, we hypothesized that the regulation of the autophagic flux by CD38 promotes collagen I degradation in CAMs resulting in cellular dysfunction that finally elicits fibrogenesis during the development of atherosclerosis.
In the present study, several in vivo and in vitro approaches were carried out to test this hypothesis. Our data demonstrate that CD38-mediated signaling pathway mediates an important autophagic regulatory mechanism by which collagen metabolism is fine controlled and that collagen deposition and arterial wall thickening in CD38 -/-mice received a high fat Western diet (WD) are associated with a deficient autophagic degradation of collagen in CAMs.
MATERIALS AND METHODS

Animal procedure
Both CD38
-/-and wild-type (CD38 +/+ ) mice on C57BL/6 background were purchased from Jackson Laboratory. CD38
+/+ and CD38 -/-mice (8 weeks of age; male) were fed for 10 weeks with normal diet or Western diet containing (g%): protein 20, carbohydrate 50, and fat 21 (Dytes, Bethlehem, PA, USA), as described previously (22) . Mice were sacrificed by cervical dislocation under ether anaesthesia. The hearts with the coronary artery were obtained, dissected or frozen in liquid nitrogen for preparation of frozen section slides. All experimental protocols were reviewed and approved by the Animal Care Committee of Virginia Commonwealth University. All animals were provided standard rodent chow and water ad libitum in a temperature-and humidity controlled room. © 1996-2017
Western blot analysis
Western blot analysis was performed as described previously (14) . Primary antibodies used are rabbit anti-collagen 1 (1:1000, Cell Signaling Technology), rabbit anti-LC3B (1:1000, Abcam), rabbit anti-matrix metalloprotein-9 (MMP-9) (1:1000, Abcam), 20S Proteasome α1 Antibody (H-95) (sc-67046, 1:500, Santa Cruz), rabbit anti-tissue inhibitor of metalloproteinase-1 (TIMP-1) (1:1000, Abcam) or goat anti-β-actin (1:500, Santa Cruz). 
Primary cell culture of mouse CAMs and treatments
CAMs were isolated from CD38 +/+ or CD38 -/-mice as previously described (23) 
Confocal microscopic analysis
For confocal analysis, cultured CAMs were grown on glass coverslips, stimulated as indicated or left unstimulated, fixed in 4% paraformaldehyde in phosphate-buffer saline (PFA/PBS) for 15 min. After permeabilization with 0.1.% Triton X-100/PBS, the cells were rinsed with PBS and incubated overnight at 4°C with indicated primary antibodies: mouse anti-collagen 1 and rabbit anti-Lamp 1 or rabbit anti-LC3B (1:200, Cell Signaling). The samples were washed and incubated with Alexa-488-or Alexa-555-labeled secondary antibodies for 1 h at room temperature. The slides were then mounted and examined using sequentially scanning on a laser scanning confocal microscope (Fluoview FV1000, Olympus, Japan), with photos taken and the co-localization analyzed by the Image Pro Plus 6.0. software (Media Cybernetics, Bethesda, MD, USA). The summarized co-localization efficiency data was expressed as Pearson correlation coefficient (PCC) as described previously (24).
Statistics
Data are presented as means ± SEM. Significant differences in mean values between-and within-multiple groups were examined using analysis of variance (ANOVA), any significant difference revealed by this procedure were further investigated using Tuckey's multiple-range test. Student's t-test was used to detect significant difference between two groups. The statistical analysis was performed by the sigmastat 3.5. software (Systat Software, Chicago, IL, USA). P<0.0.5 was considered statistically significant.
RESULTS
Effects of CD38-deficiency on collagen deposition, atherosclerosis and autophagy in the coronary artery of mice
To test the significance of CD38 in collagen I deposition in vivo, we examined the collagen I content in coronary arterial walls of CD38 +/+ and CD38 -/-mice. Figure 1A showed that the coronary arterial wall in CD38 -/-was significantly thickened by the WD treatment for 10 weeks, while that in CD38 +/+ mice was unaffected by WD feeding. As shown in Figure 1B , collagen I staining around coronary arteries was much higher in CD38 -/-than in CD38 +/+ mice on either ND or WD treatment. The content of LC3B, an autophagosome marker, was also much higher in the coronary arterial wall of CD38 -/-than of CD38 +/+ mice on either ND or WD treatment ( Figure 1C ).
Effect of CD38-deficiency on collagen I content in CAMs of CD38 -/-and CD38 +/+ mice
We next determined how CD38 deficiency affects the gene or protein expression of collagen I in primary cultured CAMs. In CAMs of CD38 -/-mice, the protein expression of collagen I increased significantly as compared to that in CD38 +/+ mice (Figure 2A,B) .
However, the mRNA abundance did not show significant difference between CD38
+/+ and CD38 -/-CAMs 
Effect of autophagy inhibition on collagen I protein levels
CD38 could increase intracellular Ca 2+ level via cADPR and NAADP, which finally leads to autophagy in CAMs. Autophagy has been proved being one of the main pathways of collagen I degradation (9) . We therefore tried to Figure out whether autophagy mediates upregulation of collagen I protein in cells lacking CD38. We treated CAMs with 3-methyladenine (3-MA), an inhibitor of autophagosome formation, or bafilomycin (baf), an inhibitor of vacuolar type H + -ATPase (V-ATPase) and demonstrated that both treatments increased the levels of LC3B and collagen I significantly in both CD38 +/+ and CD38 -/-CAMs, but the former showed a markedly higher response than the latter (Figure 3A and D) . The densitometric analysis showed that both 3-MA and Baf increased collagen levels in CAMs (B and E) which was accompanied by increased LC3B levels, an indicative of accumulated autophagosomes.
TGF-β induced more collagen I expression in CD38
-/-than in CD38 +/+ CAMs TGF-β is a key regulator of matrix proteins production, which could elicit an increase of collagen I content in smooth muscle cells. After confirming the effect of CD38 on static collagen I production of CAMs, we tried to examine the role of CD38 in stimulation of collagen I production. Figure 4A and 4B shows that TGF-β increased the collagen I protein content significantly which was more pronounced in cells deficient for CD38. TGF-β did not alter mRNA abundance of collagen I (data not shown), again suggesting a posttranslational regulation of collagen I expression. Likewise, baf also increased the level of collagen I protein in both vehicle and TGF-β treated CAMs ( Figure 4C and 4D) . 
Proteasome inhibition had no effect on collagen I accumulation of CAMs
Ubiquitin-proteasome system is another major nonlysosomal pathway for intracellular degradation of proteins. To analyze the function of the ubiquitinproteasome system for collagen I deposition, we treated CAMs with MG132, a specific, potent proteasome inhibitor. However, MG132 treatment did not change the collagen I content in vehicle or TGF-β stimulated CAMs, but it indeed inhibited TGF-β-induced proteasome marker upregulation ( Figure 5A-B) . We also tested the effects of MMP inhibitor, batimastat (Bat) (ApexBio, 3.0. μg/ml pretreatment for 30 mins) on proteasome and collagen degradation and found that Bat had no effect on both proteasome and collagen-I level under control condition or during treatment of cells with TGF-β ( Figure 5D-F) .
Effect of CD38-deficiency on MMP-9 or TIMP-1 of CAMs
MMPs are involved in the breakdown of ECM in physiological as well as in pathological processes. MMP-9/TIMP-1 has been previously reported to be involved in collagen I degradation (16) . Thus, we tested whether CD38 expression regulates MMP and TIMP-1 expression in CAMs. However, TGF-β did not change the expression of MMP-9 or TIMP-1 in CAMs significantly and there was no remarked difference between CD38 +/+ or CD38 -/-CAMs on either basal or TGF-β stimulated expression of MMP-9 or TIMP-1 (Figure 6 ).
Increased collagen I accumulation mainly localizes to lysosomes and autophagosomes of CD38 -/-CAMs
To clarify the location of collagen I accumulation, we examined whether collagen I co-localizes with Lamp1 or LC3B, specific markers of lysosomes and autophagosomes, respectively. The confocal microscopic analysis showed the co-localization of collagen I with either Lamp1 (Figure 7A and B) or LC3B ( Figure 7C and D) which was unchanged by CD38 gene deficiency in control CAM. Upon TGF-β treatment, however, the colocalization of collagen I with either Lamp1 or LC3B increased significantly, which was further enhanced in CD38 -/-CAMs.
DISCUSSION
The present study demonstrated that CD38-deficiency blocks collagen I degradation resulting in its deposition in CAMs. The accumulation of collagen I in CD38-deficient CAMs is mediated by an inhibition of autophagy in these cells.
Atherosclerosis starts with an inflammatory process that is stimulated by an increased uptake of LDL particles in the intimal space of the vessel wall. Various cytokines and growth factors then act on smooth muscle Employing real time PCR, we found the mRNA abundance did not change when the CD38 gene was knocked out suggesting a posttranslational regulation of collagen I degradation by CD38. As mentioned above, CD38 gene products can induce Ca 2+ mobilization in immunocytes contributing to cerebral injury after cardiac surgery, extracorporeal circulation, stoke, and temporary ischemia and reperfusion in the brain. Moreover, the CD38 immunopositive hepatic stellate cells (HSCs) were found correlated to fibrosis scores in patients with chronic hepatitis. Our data indicates CD38 expression in CAM may possess high capability to reduce the fibrogenesis and prevent the fibrosis of artery as compared to immunocytes and fibrocytes.
CD38-ADP-ribosylcyclase mediates signaling pathways, in particular the regulation of intracellular Ca 2+ signaling, that have critical functions in the physiology and pathophysiology of coronary arteries (7, 29) . The intracellular transport and fusion of lysosomes with autophagosome requires an increased cytosolic Ca 2+ -concentration (30, 31) , a process that is regulated by CD38 in CAMs (14) . Since autophagy mediates collagen cells to proliferate and migrate the cell as well as produce ECM proteins including collagen (25) . The formation of collagen is normally balanced by its degradation through mechanisms including autophagy (16) , proteosome (26) and MMP-1 (27) , the compromise of any of which might cause more collagen deposition. The present study demonstrates that CD38-deficiency enhanced collagen I deposition and atherosclerosis, in particular when the mice were fed with a fat-enriched WD. Simultaneously, autophagy was blocked with more LC3B present in Lamp1-positive vesicles. These results imply that under atherogenic stimulation the loss of CD38-expression causes a deregulation of autophagolysosome-formation reducing collagen I degradation and leading to deposition of collagen I around the coronary artery.
Our data further confirm that the accumulation of collagen I in CAMs of CD38 -/-mice was due to impaired degradation, but not increased production of it. Using western blot and sirius red staining which is a specific morphologic method to detect different subtypes of collagen I (28), we proved the protein content of collagen I to be increased significantly in CD38 -/-CAMs. © 1996-2017 I degradation not only in CAMs, but also in mesenchymal cell (32) , hepeatic stellate cell (33), mesangial cell (16) and cardiac cell (34), we explored whether CD38-deficiency inhibits collagen I degradation through a defect in autophagy. We used 3-MA to block the formation of autophagosomes or baf to induce lysosomal dysfunction and demonstrated that the two inhibitors increased the protein content of collagen I in both CD38 +/+ and CD38 -/-CAMs with the extent much higher in the former.
This indicates that CD38 at least partly regulates the collagen degradation by a suppression of autophagy.
In primary mouse mesangial cells, TGF-β acts as a potent inducer of fibrosis which promotes synthesis of collagen I. At the same time, it could also boost the autophagy mediated collagen I degradation. In TGF-β1 treated cell, inhibition of autophagy enhanced the collagen I deposition significantly (16, 35) . We therefore tried to testify the effect of CD38-deficiency on TGF-β induced collagen I production and degradation in CAMs. Our results showed both CD38-deficiency and lysosomal dysfunction induced by baf increased collagen I protein content of CAMs. However, the increased collagen I mRNA level evoked by TGF-β did not change in CD38
-/-CAMs (data not shown). These results suggested that CD38-deficiency or an inhibition of autophagy did not affect the synthesis of collagen I, but blocked its degradation resulting in the deposition of collagen I in CAMs.
Apart from autophagy, the ubiquitin-proteasome system and MMPs are two major non-lysosomal pathways for intracellular degradation of proteins (16, 36) . According to recent studies on mechanisms of cardiovascular diseases (26) , the ubiquitin-proteasome system is up-regulated by atherogenic stimuli promoting inflammation in endothelial and smooth muscle cells and thereby aggravating atherosclerosis damage. Thus, proteasome inhibition may attenuate collagen synthesis upon atherogenic stimulation and, therefore targeting the proteasome might be a new promising therapeutic strategy to prevent fibrosis and progression of organ failure (37, 38) . However, cellular treatment with MG132, a specific inhibitor of ubiquitin-proteasome pathway (37, 38) , did not induce any significant changes of collagen I protein content in both vehicle and TGF-β stimulated CAMs suggesting that the ubiquitinproteasome pathway may not play a major role in collagen I deposition of CAMs. TGF-β treatment may also lead to kidney fibrosis via inhibition of MMPs in mesangial cell (16) . However, we did not find any effect of CD38-deficiency on protein abundance of MMP-9 or TIMP-1, the endogenous inhibitor of MMP-9, and inhibition of MMP activity also had no effect on the collagen level in CAMs with or without treatment of TGF-β. These results indicate that in CAMs MMPs may not be a main pathway for collagen I degradation.
Finally, we employed morphological techniques to examine the distribution of the collagen I deposit inside CAMs. The results showed a significant co-localization of collagen I with either Lamp1 or LC3B strongly supporting the notion that CD38 regulates collagen I degradation through autophagy. This result is consistent with the report from Kim et al. who proved in primary cultured In summary, CD38 regulated collagen I degradation through the autophagic pathway. CD38-deficiency resulted in collagen I-deposition in CAMs mainly in lysosomes and autophagosomes. This process may result in coronary arterial fibrosis, a critical feature of atherosclerosis. Our data propose a novel way the degradation of collagen I is regulated which provide novel targets to prevent excessive collagen deposition in CAMs, a key feature of multiple pathological situations. 
